Literature DB >> 10880395

Recurrent genetic aberrations in thymoma and thymic carcinoma.

A Zettl1, P Ströbel, K Wagner, T Katzenberger, G Ott, A Rosenwald, K Peters, A Krein, M Semik, H K Müller-Hermelink, A Marx.   

Abstract

Apart from single reported aberrant karyotypes, genetic alterations in thymic epithelial neoplasms have not been investigated so far. In this study, 12 World Health Organization classification type A thymomas (medullary thymomas), 16 type B3 thymomas (well-differentiated thymic carcinomas), and nine type C thymomas, all of them primary thymic squamous cell carcinomas, were analyzed by comparative genomic hybridization and fluorescence in situ hybridization. With the exception of one single case, type A thymomas did not reveal chromosomal gains or losses in comparative genomic hybridization. In contrast, all type B3 thymomas showed chromosomal imbalances, with gain of 1q, loss of chromosome 6, and loss of 13q occurring in 11 (69%), six (38%), and five (31%) of 16 cases, respectively. In primary thymic squamous cell carcinoma, the most frequent chromosomal losses were observed for 16q (six of nine cases, 67%), 6 (4 of 9, 44%), and 3p and 17p (three of nine each, 33%), whereas recurrent gains of chromosomal material were gains of 1q (5 of 9, 56%), 17q, and 18 (three of nine each, 33%). This study shows that the distinct histological thymoma types A and B3 exhibit distinct genetic phenotypes, whereas type B3 thymoma and primary thymic squamous cell carcinoma partially share genetic aberrations. In addition to the possible tumorigenic role, the deletion in type B3 thymoma of chromosome 6, harboring the HLA locus, might play a role in the pathogenesis of paraneoplastic autoimmunity characteristic of thymoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880395      PMCID: PMC1850202          DOI: 10.1016/S0002-9440(10)64536-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  Thymoma with a t(15;22)(p11;q11).

Authors:  P Dal Cin; C De Wolf-Peeters; G Deneffe; J P Fryns; H Van den Berghe
Journal:  Cancer Genet Cytogenet       Date:  1996-07-15

2.  Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus.

Authors:  Y Fukui; T Ishimoto; M Utsuyama; T Gyotoku; T Koga; K Nakao; K Hirokawa; M Katsuki; T Sasazuki
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

Review 3.  Pathogenesis of myasthenia gravis.

Authors:  A Marx; A Wilisch; A Schultz; S Gattenlöhner; R Nenninger; H K Müller-Hermelink
Journal:  Virchows Arch       Date:  1997-05       Impact factor: 4.064

4.  Human TRK proto-oncogene maps to chromosome 1q32-q41.

Authors:  M Miozzo; M A Pierotti; G Sozzi; P Radice; I Bongarzone; N K Spurr; G Della Porta
Journal:  Oncogene       Date:  1990-09       Impact factor: 9.867

5.  Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors.

Authors:  A Abdollahi; D Roberts; A K Godwin; D C Schultz; G Sonoda; J R Testa; T C Hamilton
Journal:  Oncogene       Date:  1997-04-24       Impact factor: 9.867

6.  H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer.

Authors:  S W Lee
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

7.  No DNA copy number changes in osteochondromas: a comparative genomic hybridization study.

Authors:  M L Larramendy; J Valle; M Tarkkanen; A H Kivioja; E Karaharju; T Salmivalli; I Elomaa; S Knuutila
Journal:  Cancer Genet Cytogenet       Date:  1997-08

Review 8.  Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases.

Authors:  S Suster; C A Moran
Journal:  Am J Surg Pathol       Date:  1996-12       Impact factor: 6.394

9.  Multiple clonal chromosome aberrations in two thymomas.

Authors:  U Kristoffersson; S Heim; N Mandahl; M Akerman; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1989-08

10.  FHIT gene alterations in head and neck squamous cell carcinomas.

Authors:  L Virgilio; M Shuster; S M Gollin; M L Veronese; M Ohta; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  45 in total

1.  Chromosome 6 abnormalities correlated with thymoma progression.

Authors:  Hidefumi Sasaki; Yoshitaka Fujii; Nobuyuki Ide
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

2.  Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis.

Authors:  Se Hoon Kim; Im Suk Koh; Yang Ki Minn
Journal:  J Clin Neurol       Date:  2015-08-21       Impact factor: 3.077

3.  The World Health Organization (WHO) histologic classification of thymomas: a reanalysis.

Authors:  Cesar A Moran; Saul Suster
Journal:  Curr Treat Options Oncol       Date:  2009-02-04

4.  Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma.

Authors:  Andreas Zettl; German Ott; Angela Makulik; Tiemo Katzenberger; Petr Starostik; Thorsten Eichler; Bernhard Puppe; Martin Bentz; Hans Konrad Müller-Hermelink; Andreas Chott
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE).

Authors:  Lothar Veits; Gunhild Mechtersheimer; Christina Steger; Jens Freitag; Gregor Mikuz; Kurt W Schmid; Walter Hofmann; Peter Schirmacher; Arndt Hartmann; Ralf J Rieker
Journal:  Virchows Arch       Date:  2011-07-07       Impact factor: 4.064

Review 6.  Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Authors:  Philipp Ströbel; Alexander Marx; Andreas Zettl; Hans Konrad Müller-Hermelink
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.

Authors:  Itziar Salaverria; Cristina Royo; Alejandra Carvajal-Cuenca; Guillem Clot; Alba Navarro; Alejandra Valera; Joo Y Song; Renata Woroniecka; Grzegorz Rymkiewicz; Wolfram Klapper; Elena M Hartmann; Pierre Sujobert; Iwona Wlodarska; Judith A Ferry; Philippe Gaulard; German Ott; Andreas Rosenwald; Armando Lopez-Guillermo; Leticia Quintanilla-Martinez; Nancy L Harris; Elaine S Jaffe; Reiner Siebert; Elias Campo; Sílvia Beà
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113

8.  Intermittent weakness and mediastinal weakening.

Authors:  Umer Feroze Malik; Mersadies R Martin; Hien D Pham; Ahmed Mahmoud; Sheela Kapre
Journal:  Mcgill J Med       Date:  2009-11-16

9.  Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors.

Authors:  Iacopo Petrini; Yisong Wang; Paolo A Zucali; Hye Seung Lee; Trung Pham; Donna Voeller; Paul S Meltzer; Giuseppe Giaccone
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

10.  Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.

Authors:  Idoia Martin-Guerrero; Itziar Salaverria; Birgit Burkhardt; Monika Szczepanowski; Michael Baudis; Susanne Bens; Laurence de Leval; Africa Garcia-Orad; Heike Horn; Jasmin Lisfeld; Shoji Pellissery; Wolfram Klapper; Ilske Oschlies; Reiner Siebert
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.